Refining prognosis in BCR-ABL1-positive ALL.

摘要

In this issue of Blood, van der Veer et al report the negative prognostic impact of IKZF1 deletions in children with BCR-AB LI-positive acute lymphoblastic leukemia (ALL), despite the use of tyrosine kinase inhibitor (TKI) therapy.]